Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of Avian Influenza virus

Details for Australian Patent Application No. 2007201626 (hide)

Owner Healthbanks Biotech Co., Ltd.

Inventors Hwang, KinKai; Chang, Hsiu-Kang; Liao, Chao-Wei

Agent Spruson & Ferguson

Pub. Number AU-A-2007201626

Priority 60/791880 14.04.06 US

Filing date 13 April 2007

Wipo publication date 1 November 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/44 (2006.01) Mutation or genetic engineering

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

Event Publications

3 May 2007 Complete Application Filed

  Priority application(s): 60/791880 14.04.06 US

1 November 2007 Application Open to Public Inspection

  Published as AU-A-2007201626

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201627-Gluing layout containers

2007201625-A security device